Treatment Considerations for ASCVD & LDL-C Management

Houston Methodist DeBakey Heart and Vascular Center
Avatar

Treatment of Lipids in 2023: Where Are We Now and Where Are We Going?

By Houston Methodist DeBakey Heart and Vascular Center FEATURING Christie Ballantyne
By Houston Methodist DeBakey Heart and Vascular Center FEATURING Christie Ballantyne
4,204 views
April 5, 2023
Comments 3
Login to view comments. Click here to Login
17:04

Non-Statin Therapies for Elevated LDL-C: The Role of Inclisiran (and…

Canadian Collaborative Research Network

J. Genest

871 views
42:26

Familial Hypercholesterolemia: From Diagnosis to Treatment

Scripps Health

P. Duell

350 views
12:20

HID 2023 Insights: LDL-C - How Low Can We Go Safely?

Seth Martin

2.8K views
33:43

Update on Lipids: Current Options for Lowering LDL to Reduce CV Risk

Jefferson Health

A. Cohen

4.1K views
14:50

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

AHA 2022 Conference Coverage

K. Ray

10.8K views
23:35

ENDO 2022: Targeting PCSK9 for LDL-C Reduction

Connie Newman

1.8K views
39:44

Lipid Lowering Therapies: Where Did We Start, Where We Are Now and W…

The Texas Heart Institute

S. Virani

5.5K views
21:27

Lipids Update: Current Guidelines for Lipid Management

Scripps Health

S. R. Mehta

10.7K views
30:02

Lipid Management & Low Carb Diets

Metabolic Health Summit

B. Scher

3.8K views
41:22

Non-Statin Pharmacotherapies for Risk Reduction

Scripps Health

M. Wilkinson

3.4K views
27:51

Lipids Update: Overview of Current Guidelines for Lipid Management

Scripps Health

D. Cork

1.7K views